by DivRank | Jun 13, 2025 | Downgrades
Sherwin-Williams (SHW) was recently downgraded by Citigroup from Buy to Neutral, with a revised price target of $385. While the stock had previously been riding a wave of optimism, Citigroup’s downgrade signals potential headwinds that investors should take into...
by DivRank | Jun 13, 2025 | Downgrades
Argus has adjusted its stance on McDonald’s from Buy to Hold, signaling a recalibration of expectations after a period of solid outperformance. The downgrade stems from a softening in global foot traffic—especially in Europe and North America—as macroeconomic...
by DivRank | Jun 13, 2025 | Downgrades
Argus recently downgraded BHP Group from Buy to Hold, signaling a shift in sentiment toward the mining giant. The firm cited concerns over slowing commodity prices—particularly iron ore and copper—as the main catalyst. After a prolonged rally, these materials have...
by DivRank | Jun 11, 2025 | Downgrades
Robert W. Baird downgraded UnitedHealth from Outperform to Neutral, lowering its price target to $312. The move reflects growing concerns about Medicare Advantage margins, which are being pressured by an uptick in outpatient care utilization—particularly physician...
by DivRank | Jun 5, 2025 | Downgrades
Erste Group has downgraded Eli Lilly from Buy to Hold, citing a tempered earnings outlook for 2025. The company now expects earnings per share between $20.20 and $21.70, a signal that management is bracing for more modest growth ahead. This recalibration follows a...
by DivRank | Jun 5, 2025 | Downgrades
Berenberg has shifted its stance on Ferguson plc from “Buy” to “Hold” following a notable rally in the stock’s performance. Shares have surged roughly 25% year-to-date, nearing the firm’s updated price target of $215. With that run-up largely pricing in the near-term...
